The clinical trials below are available in the specialty you selected. Choose a different specialty.
A randomized, double-blind, placebo controlled study to assess the efficacy of LCQ908 on cardiovascular risk
This study is a proof of concept to determine if an investigational drug called LCQ908 can reduce triglyceride levels and lessen cardiovascular risk in people with cardiovascular disease. (REF# 35097)
Lifestyle, Cardiovascular Disease Risk, and Cognitive Impairment
Adults older than age 55 are needed for a study examining how exercise and diet improve cognitive function. (REF# 31464)